Online Treatment of Trichotillomania

Learn more about:
Related Clinical Trial
Internet CBT for Trichotillomania and Skin Picking Disorder Developing Effective Response Inhibition Training for Symptom Relief in OCD and Trichotillomania Evaluation and Follow-up of Individuals With Obsessive-Compulsive Disorder and Related Conditions Outcomes of Cognitive Behavioral Therapy (CBT) Interventions Provided by Unlicensed Professionals Evaluation of a Brief Surf the Urge Intervention Feasibility Study for Treating Trichotillomania With Wearable Device and App System Cognitive Behavioral Treatment of Pediatric Trichotillomania Telepsychotherapy for the Treatment of Adolescents With Trichotillomania Stepped Care in the Treatment of Trichotillomania Response Inhibition Training for Individuals With Trichotillomania Cognitive Behavioral Therapy for Trichotillomania Examining Behavior Therapy for Trichotillomania in Children and Adolescents Comprehensive Behavioral (ComB) Model of Treatment for Trichotillomania Methylphenidate in ADHD With Trichotillomania Marinol in Trichotillomania or Obsessive Compulsive Disorder Dronabinol in Trichotillomania and Other Body Focused Repetitive Behaviors Cognitive Training in Patients With Trichotillomania (Hair-pulling Disorder) Olanzapine in the Treatment of Hair Pulling (Trichotillomania) A Study in Patients With Trichotillomania Awareness Enhancement and Monitoring Device for Treatment of Trichotillomania Inositol in Trichotillomania Trial of Aripiprazole in Trichotillomania Habit Reversal Training for Children and Adolescents With Trichotillomania Naltrexone in the Treatment of Trichotillomania N-Acetylcysteine for Pediatric Trichotillomania Online Response Inhibition Training for Trichotillomania N-Acetyl Cysteine in Trichotillomania Trichotillomania: Group Cognitive-Behavioral Therapy Efficacy of COMB (Comprehensive Behavioral) Model of Treatment of Trichotillomania Milk Thistle in Trichotillomania in Children and Adults Cognitive Behavioral Group Therapy for Trichotillomania (Hair Pulling Disorder) Testing a New Therapy for Trichotillomania Online Treatment of Trichotillomania

Brief Title

Online Treatment of Trichotillomania

Official Title

Decoupling as Internet Based Intervention: an Randomized Controlled Study to Treat Trichotillomania

Brief Summary

      Online study for patients with trichotillomania. 4 main hypothesis.

        1. Alexithymia and Trichotillomania correlated and regression analyses find association
           between them

        2. we will be able to find patient who have never been treated before. Those will suffer to
           the same amount as previously treated patients

        3. Decoupling will be more helpful than progressive muscle relaxation

        4. different constructs of emotion regulation will show different trait and state
           characteristics in patients with trichotillomania
    

Detailed Description

      Randomized controlled trial with about 100 participants.
    


Study Type

Interventional


Primary Outcome

Severity of trichotillomania

Secondary Outcome

 alexithymia

Condition

Trichotillomania

Intervention

Decoupling

Study Arms / Comparison Groups

 Decoupling
Description:  specific technic to reduce hair pulling

Publications

* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.

Recruitment Information


Recruitment Status

Behavioral

Estimated Enrollment

105

Start Date

August 2011

Completion Date

December 2014

Primary Completion Date

July 2013

Eligibility Criteria

        Inclusion Criteria:

          -  suffering from trichotillomania 18 to 65 years old

        Exclusion Criteria:

          -  current drug or alcohol addiction current psychosis
      

Gender

All

Ages

18 Years - 65 Years

Accepts Healthy Volunteers

No

Contacts

Michael Rufer, MD, Prof, , 

Location Countries

Switzerland

Location Countries

Switzerland

Administrative Informations


NCT ID

NCT02044237

Organization ID

TTM


Responsible Party

Sponsor

Study Sponsor

University of Zurich

Collaborators

 Novartis

Study Sponsor

Michael Rufer, MD, Prof, Principal Investigator, University of Zurich


Verification Date

May 2016